MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.150
-0.040 (-1.83%)
Apr 1, 2025, 4:00 PM EDT - Market closed

MEI Pharma Statistics

Total Valuation

MEI Pharma has a market cap or net worth of $14.33 million. The enterprise value is -$9.15 million.

Market Cap 14.33M
Enterprise Value -9.15M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

MEI Pharma has 6.66 million shares outstanding.

Current Share Class 6.66M
Shares Outstanding 6.66M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.29%
Owned by Institutions (%) 16.03%
Float 4.94M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.66
P/TBV Ratio 0.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.66

Current Ratio 10.66
Quick Ratio 10.38
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -93.69% and return on invested capital (ROIC) is -33.73%.

Return on Equity (ROE) -93.69%
Return on Assets (ROA) -30.67%
Return on Invested Capital (ROIC) -33.73%
Return on Capital Employed (ROCE) -114.30%
Revenue Per Employee n/a
Profits Per Employee -$1.36M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.50% in the last 52 weeks. The beta is 0.63, so MEI Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change -44.50%
50-Day Moving Average 2.57
200-Day Moving Average 2.84
Relative Strength Index (RSI) 33.46
Average Volume (20 Days) 8,264

Short Selling Information

The latest short interest is 3,543, so 0.05% of the outstanding shares have been sold short.

Short Interest 3,543
Short Previous Month 5,774
Short % of Shares Out 0.05%
Short % of Float 0.07%
Short Ratio (days to cover) 0.44

Income Statement

Revenue n/a
Gross Profit -10.86M
Operating Income -25.26M
Pretax Income 26.16M
Net Income -38.22M
EBITDA -24.68M
EBIT -25.26M
Earnings Per Share (EPS) -$5.74
Full Income Statement

Balance Sheet

The company has $23.74 million in cash and n/a in debt, giving a net cash position of $23.74 million or $3.56 per share.

Cash & Cash Equivalents 23.74M
Total Debt n/a
Net Cash 23.74M
Net Cash Per Share $3.56
Equity (Book Value) 22.10M
Book Value Per Share 3.32
Working Capital 22.10M
Full Balance Sheet

Cash Flow

Operating Cash Flow -36.04M
Capital Expenditures n/a
Free Cash Flow -36.04M
FCF Per Share -$5.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MEI Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -261.91%
FCF Yield -247.01%
Dividend Details

Analyst Forecast

The average price target for MEI Pharma is $7.00, which is 225.58% higher than the current price. The consensus rating is "Hold".

Price Target $7.00
Price Target Difference 225.58%
Analyst Consensus Hold
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on April 17, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date Apr 17, 2023
Split Type Reverse
Split Ratio 0.05:1

Scores

MEI Pharma has an Altman Z-Score of -19.32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -19.32
Piotroski F-Score 2